Type |
Nasal | Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous | |
Features and Benefits |
- KLOXXADO is indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients
- KLOXXADO is supplied as a single-dose, intranasal spray containing 8 mg of naloxone hydrochloride (equivalent to 7.2 mg naloxone) in 0.1 mL
- It is a clear, colorless to yellow solution filled into a clear glass vial, stoppered and fitted with a unit-dose nasal spray device
|
- Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine
- Naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage
- The single-dose solution contains no bacteriostat, antimicrobial agent or added buffer (except for pH adjustment) and is intended for use only as a single-dose injection
- Store at 20° to 25°C (68° to 77°F)
- Protect from light by retaining in the carton until ready for use
- Single-dose glass flip top vial
- 10 vials per carton
|
- Generic Equivalent to Narcan®; Evzio™
- Luer-Jet™ needleless syringe
- Color-coded packaging - industry standard color-coding to aid in quick, reliable identification
- Emergency Syringes provided in completely needleless Luer Lock syringes, complies with OSHA's Needlestick Safety and Prevention Act and are compatible with most Luer Activated Systems (includes ICU Medical Clave® Valve)
|
- 1 mL fill in 2.5 mL Carpuject™ Single-dose cartridge with Luer Lock for the Carpuject™ Syringe System
- All Carpuject™ Luer Lock Glass Syringe (no needle) products require the use of the Carpuject™ holder, list number 02049-02, for administration
|
|